EP Patent

EP0531452A4 — Synthesis of glycerol di- and triphosphate derivatives

Assigned to Nexstar Pharmaceuticals Inc · Expires 1993-06-09 · 33y expired

What this patent protects

A process for the preparation of glycerophospholipid derivatives comprising coupling the phosphate group of a glycerol monophosphate derivative in which one of the phosphate hydroxyls is replaced by a leaving group, with the terminal phosphate group of a mono- or diphosphate comp…

USPTO Abstract

A process for the preparation of glycerophospholipid derivatives comprising coupling the phosphate group of a glycerol monophosphate derivative in which one of the phosphate hydroxyls is replaced by a leaving group, with the terminal phosphate group of a mono- or diphosphate compound or a salt thereof, in the presence of a basic catalyst, under anhydrous conditions.

Drugs covered by this patent

Patent Metadata

Patent number
EP0531452A4
Jurisdiction
EP
Classification
Expires
1993-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Nexstar Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.